Merck aims to hike revenues in China to 1 bln eur by 2018

FRANKFURT, July 26 Sat Jul 26, 2014 7:35am EDT

Related Topics

FRANKFURT, July 26 (Reuters) - Merck will start offering non-prescription drugs in China as part of a push to double revenues in the region to 1 billion euros ($1.3 billion) by 2018, Chief Executive Karl-Ludwig Kley told German weekly Wirtschaftswoche.

Merck will focus on treatments related to diabetes, thyroid issues and heart problems, and supply medication made at a new factory in Nantong which is due to start production in 2017, Wirtschaftswoche said. ($1 = 0.7447 Euros) (Reporting by Edward Taylor; Editing by Ruth Pitchford)